Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record.

Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children

Open access
Covar, Ronina A., Szefler, Stanley J., Zeiger, Robert S., Sorkness, Christine A., Moss, Mark, Mauger, David T., Boehmer, Susan J., Strunk, Robert C., Martinez, Fernando D., Taussig, Lynn M.·2008·Journal of Allergy and Clinical Immunology

Abstract

Background Asthma exacerbations are a common cause of critical illness in children. Objective To determine factors associated with exacerbations in children with persistent asthma. Methods Regression modeling was used to identify historical, phenotypic, treatment, and time-dependent factors associated with the occurrence of exacerbations, defined by need for oral corticosteroids, emergency or hospital care in the 48-week Pediatric Asthma Controller Trial (PACT) study. Children aged 6–14 with mild to moderate persistent asthma were randomized to receive either fluticasone propionate 100 mcg BID (FP monotherapy), combination fluticasone 100 mcg AM and salmeterol BID, or montelukast 5 mg once daily. Results Of the 285 participants randomized, 48% had 231 exacerbations. Using a multivariate analysis, which included numerous demographic, pulmonary, and inflammatory parameters, only a history of an asthma exacerbation requiring a systemic corticosteroid in the past year (odds ratio 2.10, p<0.001) was associated with a subsequent exacerbation during the trial. During the trial, treatment with montelukast vs. FP monotherapy (OR 2.00, p=0.005), season (spring, fall, or winter vs. summer, p=<0.001), and average seasonal 5% reduction in AM peak expiratory flow (PEF) (OR 1.21, p=0.01) were each associated with exacerbations. Changes in worsening of symptoms, beta-agonist use, and low PEF track together before an exacerbation, but have poor positive predictive value of exacerbation. Conclusion Children with mild to moderate persistent asthma with prior exacerbations are more likely to have a repeat exacerbation despite controller treatment. Inhaled corticosteroids are superior to montelukast at modifying the exacerbation risk. Available physiologic measures and biomarkers, and diary card tracking are not reliable predictors of asthma exacerbations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2008.08.021

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 173

Metadata

Authors
Covar, R. A., Szefler, S. J., Zeiger, R. S., Sorkness, C. A., Moss, M., Mauger, D. T., Boehmer, S. J., Strunk, R. C., Martinez, F. D., & Taussig, L. M.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2008-10
Volume
122
Issue
4
Pages
741-747.e4
ISSN
0091-6749 (ISSN-L)
OpenAlex
W1971145825
Cited by
173
References
0
FWCI
8.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. https://app.cochat.ai/papers/10.1016/j.jaci.2008.08.021
The paper
Covar, R. A., Szefler, S. J., Zeiger, R. S., Sorkness, C. A., Moss, M., Mauger, D. T., Boehmer, S. J., Strunk, R. C., Martinez, F. D., & Taussig, L. M. (2008). Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2008.08.021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.